Brief: Neurosense Therapeutics says Granted Patents In Europe, Japan, And Israel For Its Als Drug Primec

Neurosense Therapeutics

19/09/2023 14:08

Sept 19 (Reuters) - Neurosense Therapeutics Ltd
 NRSN.O :
    * NEUROSENSE THERAPEUTICS LTD - GRANTED PATENTS IN EUROPE,
JAPAN,
AND ISRAEL FOR ITS ALS DRUG PRIMEC
    * NEUROSENSE THERAPEUTICS LTD - CLINICAL TOPLINE RESULTS
FROM
PHASE 2B ALS TRIAL EXPECTED IN H2 2023

Source text for Eikon:  ID:nPn4Rr44xa 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com))